Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Activin is a growth and differentiation factor of many cell types, and has recently been implicated in inflammatory processes. Clinical data linking activin and its binding protein, follistatin (FS), are lacking. We measured serum levels of activin and FS in patients diagnosed with septicemia. PATIENTS AND MEASUREMENTS: Eight male and seven female patients of different ages, various forms of septicemia and different clinical outcome were investigated and compared with age- and sex-matched healthy controls. Serum concentrations of FS, activin, C-reactive protein (CRP) and blood leukocyte counts were determined during septicemia. RESULTS: The median of the maximum activin concentrations of septicemic patients was 3.9-fold higher than in age- and sex-matched healthy control subjects (P<0.01); the median of the maximum FS concentrations was 2.6-fold higher (P<0.01). The highest increase of activin in septicemic patients was approximately 15.8-fold, whereas FS increased by up to 13.2-fold above normal. FS, activin and CRP serum levels generally paralleled each other, but were not correlated with leukocyte counts or clinical outcome. CONCLUSIONS: Circulatory concentrations of activin and FS are elevated in patients diagnosed with septicemia, consistent with potential roles in the systemic inflammatory response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz-Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha-Hikim, I., Hogue, A., Fielder, T. J., & Gonzalez-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294
Jones, K. L., Mansell, A., Patella, S., Scott, B. J., Hedger, M. P., de Kretser, D. M., & Phillips, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705971104 · Cited by 280
Self-citationWinbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201109091 · Cited by 218
“…(EMD) was dissolved overnight in a solution containing 0.2% carboxymethylcellulose Our findings raise the question as to how the inhibition of specific TGF- family ligands and a resultant diminution of Smad3 activity can potentiate the Akt/mTOR/S6K/S6RP signaling cascade in skeletal muscle.”
InfluentialRoles of activin in tissue repair, fibrosis, and inflammatory disease
WERNER, S., & ALZHEIMER, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.001 · Cited by 209
Metadata
- Authors
- Michel, U., Ebert, S., Phillips, D., & Nau, R.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-05-01
- Volume
- 148
- Issue
- 5
- Pages
- 559-564
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2067935802
- Cited by
- 95
- References
- 0
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. https://app.cochat.ai/papers/10.1530/eje.0.1480559
- The paper
- Michel, U., Ebert, S., Phillips, D., & Nau, R. (2003). Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1480559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.